Publication | Open Access

Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor

Drug TargetBiochemistryKappa-opioid ReceptorMedicineFunctional SelectivityRational Drug DesignMechanism Of ActionNeuropharmacologyNon-peptide LigandMichael Acceptor ApproachPharmacologyDrug Discovery